EXEL.NASDAQExelixis, INC

Form 4: Exelixis CEO Morrissey Gifts Shares, Receives New RSU Grant

Sentiment:

Executive Compensation Update


Exelixis President and CEO Michael Morrissey reported a gift of 100,278 shares and the grant of 160,437 restricted stock units.

Summary

  • Michael Morrissey, President and CEO of Exelixis, Inc., gifted 100,278 shares of common stock to the Bombora Rise Foundation on February 24, 2026.
  • On February 26, 2026, Morrissey was granted 160,437 restricted stock units (RSUs) under the Exelixis, Inc. 2017 Equity Incentive Plan.
  • These RSUs will vest in four equal annual installments, with the first vesting on May 15, 2027, and subsequent vestings on each May 15th thereafter until fully vested.
  • Following these transactions, Morrissey's beneficial ownership includes 1,989,956 shares held indirectly by a family trust, 1,614,552 shares held directly (including unvested RSUs and performance-based restricted stock units), and 17,728 shares held indirectly via a 401(k) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, primarily due to the significant RSU grant which aligns executive incentives with long-term company performance, outweighing the minor share gift.

Positives

  • The grant of 160,437 restricted stock units (RSUs) to the CEO indicates continued long-term incentive alignment with shareholder interests.
  • The vesting schedule for the RSUs extends over several years, reinforcing management's commitment to the company's sustained performance.

Negatives

  • The gift of 100,278 shares by the CEO reduces his direct beneficial ownership, though it represents a relatively small percentage of his total holdings.

Future Outlook

The grant of restricted stock units with a multi-year vesting schedule, commencing May 15, 2027, indicates a long-term incentive structure for the CEO, aligning his future compensation with the company's sustained performance over the coming years.

Industry Context

StockSavvy.ai notes that executive compensation, particularly through equity grants like RSUs, is a standard practice in the biotechnology and pharmaceutical industry to align management incentives with long-term shareholder value creation. The gifting of shares, while reducing direct ownership, is also a common practice for philanthropic or estate planning purposes among high-net-worth individuals.

Related Party Transactions

  • The gift of 100,278 shares to the Bombora Rise Foundation could be considered a related party transaction if the foundation has ties to the reporting person, though the filing does not provide details on the foundation's nature beyond its name.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the CEO's interests with long-term shareholder value. The gift of shares has a negligible impact on overall outstanding shares.

Next Steps

  • Vesting of 1/4th of the 160,437 RSUs on May 15, 2027.
  • Subsequent annual vesting of 1/4th of the RSUs on each May 15th until fully vested.

Key Dates

DateDescription
1994-07-21Date of the Morrissey Family Living Trust.
2017Year of the Exelixis, Inc. Equity Incentive Plan under which RSUs were granted.
2025-03-31Date of grant for the One-Time Award PSUs included in direct holdings.
2026-02-24Date Michael Morrissey gifted 100,278 shares of common stock to the Bombora Rise Foundation.
2026-02-26Date Michael Morrissey was granted 160,437 restricted stock units (RSUs) and the date of the 401(k) plan statement.
2026-03-02Signature date of the Form 4 filing.
2027-05-15First vesting date for 1/4th of the 160,437 RSUs granted on February 26, 2026.

Recommendation

hold

This Form 4 filing details routine insider transactions, specifically an RSU grant and a share gift, which are standard executive compensation and personal financial planning activities. It does not contain information that would fundamentally alter the investment thesis for Exelixis, nor does it provide new operational or financial performance data. Therefore, a "hold" recommendation is appropriate as these transactions do not present a compelling reason to buy or sell based solely on this filing.

Keywords

Exelixis, EXEL, Michael Morrissey, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Stock Gift, Executive Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.